Supporting the designation of May 2025 as "National Myositis Awareness Month".
- Bill Number
- H.Res. 277
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-03-31: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-04-27T20:16:29Z
AI-Generated Summary
Purpose
This resolution aims to support the designation of May 2025 as "National Myositis Awareness Month" to raise public awareness about myositis, a group of rare, chronic autoimmune diseases that cause muscle inflammation and other symptoms like pain, fatigue, and swallowing difficulties.
Key Provisions
- Background on Myositis: Recognizes that nearly 1 in 10 Americans has a rare disease, including myositis (also known as idiopathic inflammatory myopathies). It highlights specific types such as dermatomyositis, polymyositis, inclusion body myositis, and others, noting challenges like delayed diagnosis, lack of cures, shortened life expectancy (especially for inclusion body myositis), and health disparities for women and people of color.
- Need for Awareness and Research: Emphasizes the need for more research into causes and treatments, difficulties in finding expert care, and the role of May campaigns in educating about detection and treatment.
- Resolution Actions:
- Supports the designation of "National Myositis Awareness Month."
- Acknowledges the impact of myositis on U.S. veterans and citizens.
- Encourages the public to learn more about myositis and support affected individuals and families.
Significant Changes to Existing Law
This is a non-binding House resolution with no legal force, so it introduces no changes to existing laws or statutes. It serves as a symbolic expression of congressional support rather than enacting new rules or requirements.
Potential Impacts
- On Citizens: May increase public education and awareness, potentially leading to earlier diagnoses, better access to care, and reduced stigma for those with myositis, though it does not allocate funding or mandate actions.
- On Government Agencies: Minimal direct impact; it could indirectly encourage federal health agencies (like the National Institutes of Health) to prioritize myositis research, but no specific obligations are imposed.
- On International Relations: None, as the resolution focuses solely on domestic awareness for U.S. residents.
Main Stakeholders Affected
- Individuals with Myositis: Patients, including veterans, who may benefit from heightened awareness and support.
- Families and Caregivers: Those supporting affected loved ones, encouraged to receive public recognition and resources.
- Healthcare Providers: Doctors and specialists dealing with diagnosis and treatment challenges.
- The General Public: Urged to become informed, potentially fostering broader community support.
- Advocacy Groups: Organizations promoting rare disease awareness, which align with the May campaigns.
Notable Legal, Constitutional, or Political Implications
- Legal/Constitutional: No significant implications, as this is a simple resolution under House rules, not requiring presidential approval or affecting rights. It aligns with Congress's power to express policy preferences without binding effect.
- Political: Represents bipartisan interest in rare disease advocacy (introduced by Mr. McCormick and referred to the Committee on Energy and Commerce). It could signal growing congressional attention to autoimmune and rare conditions, potentially influencing future funding bills, but remains symbolic.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. McCormick, Richard [R-GA-7]
Cosponsors (2)
Rep. Tonko, Paul [D-NY-20], Rep. Ellzey, Jake [R-TX-6]
Recent Actions
- 2025-03-31: Referred to the House Committee on Energy and Commerce.
- 2025-03-31: Submitted in House
- 2025-03-31: Submitted in House
Bill Versions
- Supporting the designation of May 2025 as "National Myositis Awareness Month". — issued 2025-03-31 — PDF (2 pages)